SkinBioTherapeutics plc (AIM:SBTX)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 5.00
-0.25 (-4.76%)
Nov 5, 2026, 4:22 PM GMT
SkinBioTherapeutics Market Cap
SkinBioTherapeutics has a market cap or net worth of 12.96 million as of November 5, 2026. It is the 37,709th most valuable company in the world and the 818th biggest in the United Kingdom. Its market cap has decreased by 68.95% in one year.
Market Cap
12.96M
Enterprise Value
10.77M
Revenue
5.23M
Global Rank
Country Rank
#818 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since April 5, 2017, SkinBioTherapeutics's market cap has decreased from 15.73M to 12.96M, a decrease of -17.61%. That is a compound annual growth rate of -2.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 12.96M | -68.21% |
| Dec 31, 2025 | 40.76M | -3.56% |
| Dec 31, 2024 | 42.26M | 45.57% |
| Dec 29, 2023 | 29.03M | 8.17% |
| Dec 30, 2022 | 26.84M | -59.24% |
| Dec 31, 2021 | 65.85M | 79.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sareum Holdings | 25.36M |
| ImmuPharma | 22.01M |
| Oxford BioDynamics | 13.68M |
| Thalia Therapeutics | 10.65M |
| Genflow Biosciences | 10.20M |
| Aptamer Group | 9.34M |
| Fusion Antibodies | 7.36M |
| Palatin Technologies | 7.28M |